Fear Avoidance Beliefs in Upper-Extremity Musculoskeletal Pain Conditions: Secondary Analysis of a Prospective Clinical Study on Digital Care Programs.

" : Funding sources: The study sponsor, SWORD Health, was involved in study design, data collection, and interpretation and writing of the manuscript.: Conflicts of interest: Dora Janela, Fabíola Costa, Maria Molinos, Virgílio Bento, Fernando Correia and Vijay Yanamadala are employees of SWORD Health, the study sponsor. Fernando Correia, Vijay Yanamadala and Virgílio Bento also hold equity from SWORD Health. Robert Moulder is an independent scientific consultant responsible for statistical analysis, while Steven Cohen, Jorge Lains and Justin Scheer are independent scientific/clinical consultants who were funded by SWORD Health in connection with the development and execution of this article.: Trial registration: ClinicalTrials.gov, NCT04092946. Registered 17/09/2019; https://clinicaltrials.gov/ct2/show/NCT04092946."

" : Funding sources: The study sponsor, SWORD Health, was involved in study design, data collection, and interpretation and writing of the manuscript.: Conflicts of interest: Dora Janela, Fabíola Costa, Maria Molinos, Virgílio Bento, Fernando Correia and Vijay Yanamadala are employees of SWORD Health, the study sponsor. Fernando Correia, Vijay Yanamadala and Virgílio Bento also hold equity from SWORD Health. Robert Moulder is an independent scientific consultant responsible for statistical analysis, while Steven Cohen, Jorge Lains and Justin Scheer are independent scientific/clinical consultants who were funded by SWORD Health in connection with the development and execution of this article.: Trial registration: ClinicalTrials.gov, NCT04092946. Registered 17/09/2019; https://clinicaltrials.gov/ct2/show/NCT04092946."

"This is a secondary analysis of data collected within a prospective, decentralized study approved by the New England Institutional Review Board (number 120190313) and registered on ClinicalTrials.gov (NCT04092946) on September 17, 2019. This ongoing study is focused on assessing clinical and engagement-related outcomes in patients with MSK pain after a home-based multimodal DCP. The present study focused on individuals with UEMSK pain conditions and high levels of FAB (≥15) who underwent the DCP between June 19, 2020, and November 23, 2021. Previous studies have demonstrated that a score ≥15 on the fear-avoidance beliefs questionnaire for physical activity (FABQ-PA) is associated with poorer prognosis [].  : Funding sources: The study sponsor, SWORD Health, was involved in study design, data collection, and interpretation and writing of the manuscript.: Conflicts of interest: Dora Janela, Fabíola Costa, Maria Molinos, Virgílio Bento, Fernando Correia and Vijay Yanamadala are employees of SWORD Health, the study sponsor. Fernando Correia, Vijay Yanamadala and Virgílio Bento also hold equity from SWORD Health. Robert Moulder is an independent scientific consultant responsible for statistical analysis, while Steven Cohen, Jorge Lains and Justin Scheer are independent scientific/clinical consultants who were funded by SWORD Health in connection with the development and execution of this article.: Trial registration: ClinicalTrials.gov, NCT04092946. Registered 17/09/2019; https://clinicaltrials.gov/ct2/show/NCT04092946."